APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Disease Nutritional Intervention Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chronic Disease Nutritional Intervention Solution Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchChronic Disease Nutritional Intervention Solution Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Disease Nutritional Intervention Solution Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Chronic Disease Nutritional Intervention Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Disease Nutritional Intervention Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Chronic Disease Nutritional Intervention Solution Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global Chronic Disease Nutritional Intervention Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chronic Disease Nutritional Intervention Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Disease Nutritional Intervention Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Disease Nutritional Intervention Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chronic Disease Nutritional Intervention Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chronic Disease Nutritional Intervention Solution market include Noom, Livongo Health, Hinge Health, Dexcom, Amwell, Nutrino, Zoe, Lumen and DayTwo, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chronic Disease Nutritional Intervention Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Disease Nutritional Intervention Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Disease Nutritional Intervention Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chronic Disease Nutritional Intervention Solution market.

Chronic Disease Nutritional Intervention Solution Segment by Company

Noom

Livongo Health

Hinge Health

Dexcom

Amwell

Nutrino

Zoe

Lumen

DayTwo

Nutritics

Bitesnap

Nutrix

Spoon Guru

Abbott

Gushengtang Holdings

Dong-E-E-Jiao

Miaoyijia Information Technology

Ping An Healthcare And Technology Company

WeDoctor

Shanzhen

Chronic Disease Nutritional Intervention Solution Segment by Type

Basic Dietary Guidance Plan

Functional Food Intervention Plan

Medical Nutrition Therapy Plan

Chronic Disease Nutritional Intervention Solution Segment by Application

Healthcare Industry

Elderly Care Industry

Health Science Industry

Others

Chronic Disease Nutritional Intervention Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chronic Disease Nutritional Intervention Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chronic Disease Nutritional Intervention Solution key companies, revenue, market share, and recent developments.

3. To split the Chronic Disease Nutritional Intervention Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chronic Disease Nutritional Intervention Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chronic Disease Nutritional Intervention Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Chronic Disease Nutritional Intervention Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Disease Nutritional Intervention Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Disease Nutritional Intervention Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Disease Nutritional Intervention Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chronic Disease Nutritional Intervention Solution industry.

Chapter 3: Detailed analysis of Chronic Disease Nutritional Intervention Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chronic Disease Nutritional Intervention Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chronic Disease Nutritional Intervention Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chronic Disease Nutritional Intervention Solution Industry Trends Table 2. Chronic Disease Nutritional Intervention Solution Industry Drivers Table 3. Chronic Disease Nutritional Intervention Solution Industry Opportunities and Challenges Table 4. Chronic Disease Nutritional Intervention Solution Industry Restraints Table 5. Global Chronic Disease Nutritional Intervention Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chronic Disease Nutritional Intervention Solution Revenue Share by Company (2021-2026) Table 7. Global Chronic Disease Nutritional Intervention Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chronic Disease Nutritional Intervention Solution Key Company Manufacturing Base & Headquarters Table 9. Global Chronic Disease Nutritional Intervention Solution Company, Product Type & Application Table 10. Global Chronic Disease Nutritional Intervention Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chronic Disease Nutritional Intervention Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Basic Dietary Guidance Plan Table 15. Significant Companies of Functional Food Intervention Plan Table 16. Significant Companies of Medical Nutrition Therapy Plan Table 17. Global Chronic Disease Nutritional Intervention Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Chronic Disease Nutritional Intervention Solution Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Chronic Disease Nutritional Intervention Solution Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Type (2021-2026) Table 21. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Healthcare Industry Table 23. Significant Companies of Elderly Care Industry Table 24. Significant Companies of Health Science Industry Table 25. Significant Companies of Others Table 26. Global Chronic Disease Nutritional Intervention Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Chronic Disease Nutritional Intervention Solution Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Chronic Disease Nutritional Intervention Solution Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Application (2021-2026) Table 30. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Application (2027-2032) Table 31. Global Chronic Disease Nutritional Intervention Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Chronic Disease Nutritional Intervention Solution Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Region (2021-2026) Table 34. Global Chronic Disease Nutritional Intervention Solution Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Region (2027-2032) Table 36. Global Chronic Disease Nutritional Intervention Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Chronic Disease Nutritional Intervention Solution Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Chronic Disease Nutritional Intervention Solution Sales Value Market Share by Country (2021-2026) Table 39. Global Chronic Disease Nutritional Intervention Solution Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Chronic Disease Nutritional Intervention Solution Sales Value Market Share by Country (2027-2032) Table 41. Noom Company Information Table 42. Noom Business Overview Table 43. Noom Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Noom Chronic Disease Nutritional Intervention Solution Product Portfolio Table 45. Noom Recent Development Table 46. Livongo Health Company Information Table 47. Livongo Health Business Overview Table 48. Livongo Health Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Livongo Health Chronic Disease Nutritional Intervention Solution Product Portfolio Table 50. Livongo Health Recent Development Table 51. Hinge Health Company Information Table 52. Hinge Health Business Overview Table 53. Hinge Health Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Hinge Health Chronic Disease Nutritional Intervention Solution Product Portfolio Table 55. Hinge Health Recent Development Table 56. Dexcom Company Information Table 57. Dexcom Business Overview Table 58. Dexcom Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Dexcom Chronic Disease Nutritional Intervention Solution Product Portfolio Table 60. Dexcom Recent Development Table 61. Amwell Company Information Table 62. Amwell Business Overview Table 63. Amwell Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Amwell Chronic Disease Nutritional Intervention Solution Product Portfolio Table 65. Amwell Recent Development Table 66. Nutrino Company Information Table 67. Nutrino Business Overview Table 68. Nutrino Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Nutrino Chronic Disease Nutritional Intervention Solution Product Portfolio Table 70. Nutrino Recent Development Table 71. Zoe Company Information Table 72. Zoe Business Overview Table 73. Zoe Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Zoe Chronic Disease Nutritional Intervention Solution Product Portfolio Table 75. Zoe Recent Development Table 76. Lumen Company Information Table 77. Lumen Business Overview Table 78. Lumen Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Lumen Chronic Disease Nutritional Intervention Solution Product Portfolio Table 80. Lumen Recent Development Table 81. DayTwo Company Information Table 82. DayTwo Business Overview Table 83. DayTwo Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. DayTwo Chronic Disease Nutritional Intervention Solution Product Portfolio Table 85. DayTwo Recent Development Table 86. Nutritics Company Information Table 87. Nutritics Business Overview Table 88. Nutritics Chronic Disease Nutritional Intervention Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Nutritics Chronic Disease Nutritional Intervention Solution Product Portfolio Table 90. Nutritics Recent Development Table 91. Bitesnap Company Information Table 92. Bitesnap Business Overview Table 93. Bitesnap Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Bitesnap Chronic Disease Nutritional Intervention Solution Product Portfolio Table 95. Bitesnap Recent Development Table 96. Nutrix Company Information Table 97. Nutrix Business Overview Table 98. Nutrix Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Nutrix Chronic Disease Nutritional Intervention Solution Product Portfolio Table 100. Nutrix Recent Development Table 101. Spoon Guru Company Information Table 102. Spoon Guru Business Overview Table 103. Spoon Guru Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Spoon Guru Chronic Disease Nutritional Intervention Solution Product Portfolio Table 105. Spoon Guru Recent Development Table 106. Abbott Company Information Table 107. Abbott Business Overview Table 108. Abbott Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Abbott Chronic Disease Nutritional Intervention Solution Product Portfolio Table 110. Abbott Recent Development Table 111. Gushengtang Holdings Company Information Table 112. Gushengtang Holdings Business Overview Table 113. Gushengtang Holdings Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Gushengtang Holdings Chronic Disease Nutritional Intervention Solution Product Portfolio Table 115. Gushengtang Holdings Recent Development Table 116. Dong-E-E-Jiao Company Information Table 117. Dong-E-E-Jiao Business Overview Table 118. Dong-E-E-Jiao Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Dong-E-E-Jiao Chronic Disease Nutritional Intervention Solution Product Portfolio Table 120. Dong-E-E-Jiao Recent Development Table 121. Miaoyijia Information Technology Company Information Table 122. Miaoyijia Information Technology Business Overview Table 123. Miaoyijia Information Technology Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Miaoyijia Information Technology Chronic Disease Nutritional Intervention Solution Product Portfolio Table 125. Miaoyijia Information Technology Recent Development Table 126. Ping An Healthcare And Technology Company Company Information Table 127. Ping An Healthcare And Technology Company Business Overview Table 128. Ping An Healthcare And Technology Company Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Ping An Healthcare And Technology Company Chronic Disease Nutritional Intervention Solution Product Portfolio Table 130. Ping An Healthcare And Technology Company Recent Development Table 131. WeDoctor Company Information Table 132. WeDoctor Business Overview Table 133. WeDoctor Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. WeDoctor Chronic Disease Nutritional Intervention Solution Product Portfolio Table 135. WeDoctor Recent Development Table 136. Shanzhen Company Information Table 137. Shanzhen Business Overview Table 138. Shanzhen Chronic Disease Nutritional Intervention Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Shanzhen Chronic Disease Nutritional Intervention Solution Product Portfolio Table 140. Shanzhen Recent Development Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Chronic Disease Nutritional Intervention Solution Product Image Figure 2. Global Chronic Disease Nutritional Intervention Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Disease Nutritional Intervention Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Disease Nutritional Intervention Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Basic Dietary Guidance Plan Image Figure 8. Functional Food Intervention Plan Image Figure 9. Medical Nutrition Therapy Plan Image Figure 10. Global Chronic Disease Nutritional Intervention Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Chronic Disease Nutritional Intervention Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Type (2021-2032) Figure 13. Healthcare Industry Image Figure 14. Elderly Care Industry Image Figure 15. Health Science Industry Image Figure 16. Others Image Figure 17. Global Chronic Disease Nutritional Intervention Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Chronic Disease Nutritional Intervention Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Application (2021-2032) Figure 20. Global Chronic Disease Nutritional Intervention Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032) & (US$ Million) Figure 23. North America Chronic Disease Nutritional Intervention Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Chronic Disease Nutritional Intervention Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Chronic Disease Nutritional Intervention Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032) & (US$ Million) Figure 29. South America Chronic Disease Nutritional Intervention Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Chronic Disease Nutritional Intervention Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Basic Dietary Guidance Plan
  • Functional Food Intervention Plan
  • Medical Nutrition Therapy Plan
Applications
  • Healthcare Industry
  • Elderly Care Industry
  • Health Science Industry
  • Others
Companies covered
  • Noom
  • Livongo Health
  • Hinge Health
  • Dexcom
  • Amwell
  • Nutrino
  • Zoe
  • Lumen
  • DayTwo
  • Nutritics
  • Bitesnap
  • Nutrix
  • Spoon Guru
  • Abbott
  • Gushengtang Holdings
  • Dong-E-E-Jiao
  • Miaoyijia Information Technology
  • Ping An Healthcare And Technology Company
  • WeDoctor
  • Shanzhen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chronic Disease Nutritional Intervention Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chronic Disease Nutritional Intervention Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chronic Disease Nutritional Intervention Solution Market Dynamics
  1. 2.1 Chronic Disease Nutritional Intervention Solution Industry Trends
  2. 2.2 Chronic Disease Nutritional Intervention Solution Industry Drivers
  3. 2.3 Chronic Disease Nutritional Intervention Solution Industry Opportunities and Challenges
  4. 2.4 Chronic Disease Nutritional Intervention Solution Industry Restraints
3 Chronic Disease Nutritional Intervention Solution Market by Company
  1. 3.1 Global Chronic Disease Nutritional Intervention Solution Company Revenue Ranking in 2025
  2. 3.2 Global Chronic Disease Nutritional Intervention Solution Revenue by Company (2021-2026)
  3. 3.3 Global Chronic Disease Nutritional Intervention Solution Company Ranking (2024-2026)
  4. 3.4 Global Chronic Disease Nutritional Intervention Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Chronic Disease Nutritional Intervention Solution Company Product Type and Application
  6. 3.6 Global Chronic Disease Nutritional Intervention Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chronic Disease Nutritional Intervention Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chronic Disease Nutritional Intervention Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chronic Disease Nutritional Intervention Solution Market by Type
  1. 4.1 Chronic Disease Nutritional Intervention Solution Type Introduction
  2. 4.1.1 Basic Dietary Guidance Plan
  3. 4.1.2 Functional Food Intervention Plan
  4. 4.1.3 Medical Nutrition Therapy Plan
  5. 4.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Type
  6. 4.2.1 Global Chronic Disease Nutritional Intervention Solution Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Type (2021-2032)
  8. 4.2.3 Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Type (2021-2032)
5 Chronic Disease Nutritional Intervention Solution Market by Application
  1. 5.1 Chronic Disease Nutritional Intervention Solution Application Introduction
  2. 5.1.1 Healthcare Industry
  3. 5.1.2 Elderly Care Industry
  4. 5.1.3 Health Science Industry
  5. 5.1.4 Others
  6. 5.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Application
  7. 5.2.1 Global Chronic Disease Nutritional Intervention Solution Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Application (2021-2032)
  9. 5.2.3 Global Chronic Disease Nutritional Intervention Solution Sales Value Share by Application (2021-2032)
6 Chronic Disease Nutritional Intervention Solution Regional Value Analysis
  1. 6.1 Global Chronic Disease Nutritional Intervention Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chronic Disease Nutritional Intervention Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032)
  7. 6.3.2 North America Chronic Disease Nutritional Intervention Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Chronic Disease Nutritional Intervention Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chronic Disease Nutritional Intervention Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032)
  16. 6.6.2 South America Chronic Disease Nutritional Intervention Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chronic Disease Nutritional Intervention Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chronic Disease Nutritional Intervention Solution Sales Value Share by Country, 2025 VS 2032
7 Chronic Disease Nutritional Intervention Solution Country-level Value Analysis
  1. 7.1 Global Chronic Disease Nutritional Intervention Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chronic Disease Nutritional Intervention Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chronic Disease Nutritional Intervention Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chronic Disease Nutritional Intervention Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chronic Disease Nutritional Intervention Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chronic Disease Nutritional Intervention Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Noom
  2. 8.1.1 Noom Company Information
  3. 8.1.2 Noom Business Overview
  4. 8.1.3 Noom Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Noom Chronic Disease Nutritional Intervention Solution Product Portfolio
  6. 8.1.5 Noom Recent Developments
  7. 8.2 Livongo Health
  8. 8.2.1 Livongo Health Company Information
  9. 8.2.2 Livongo Health Business Overview
  10. 8.2.3 Livongo Health Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Livongo Health Chronic Disease Nutritional Intervention Solution Product Portfolio
  12. 8.2.5 Livongo Health Recent Developments
  13. 8.3 Hinge Health
  14. 8.3.1 Hinge Health Company Information
  15. 8.3.2 Hinge Health Business Overview
  16. 8.3.3 Hinge Health Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hinge Health Chronic Disease Nutritional Intervention Solution Product Portfolio
  18. 8.3.5 Hinge Health Recent Developments
  19. 8.4 Dexcom
  20. 8.4.1 Dexcom Company Information
  21. 8.4.2 Dexcom Business Overview
  22. 8.4.3 Dexcom Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dexcom Chronic Disease Nutritional Intervention Solution Product Portfolio
  24. 8.4.5 Dexcom Recent Developments
  25. 8.5 Amwell
  26. 8.5.1 Amwell Company Information
  27. 8.5.2 Amwell Business Overview
  28. 8.5.3 Amwell Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Amwell Chronic Disease Nutritional Intervention Solution Product Portfolio
  30. 8.5.5 Amwell Recent Developments
  31. 8.6 Nutrino
  32. 8.6.1 Nutrino Company Information
  33. 8.6.2 Nutrino Business Overview
  34. 8.6.3 Nutrino Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nutrino Chronic Disease Nutritional Intervention Solution Product Portfolio
  36. 8.6.5 Nutrino Recent Developments
  37. 8.7 Zoe
  38. 8.7.1 Zoe Company Information
  39. 8.7.2 Zoe Business Overview
  40. 8.7.3 Zoe Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zoe Chronic Disease Nutritional Intervention Solution Product Portfolio
  42. 8.7.5 Zoe Recent Developments
  43. 8.8 Lumen
  44. 8.8.1 Lumen Company Information
  45. 8.8.2 Lumen Business Overview
  46. 8.8.3 Lumen Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lumen Chronic Disease Nutritional Intervention Solution Product Portfolio
  48. 8.8.5 Lumen Recent Developments
  49. 8.9 DayTwo
  50. 8.9.1 DayTwo Company Information
  51. 8.9.2 DayTwo Business Overview
  52. 8.9.3 DayTwo Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DayTwo Chronic Disease Nutritional Intervention Solution Product Portfolio
  54. 8.9.5 DayTwo Recent Developments
  55. 8.10 Nutritics
  56. 8.10.1 Nutritics Company Information
  57. 8.10.2 Nutritics Business Overview
  58. 8.10.3 Nutritics Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nutritics Chronic Disease Nutritional Intervention Solution Product Portfolio
  60. 8.10.5 Nutritics Recent Developments
  61. 8.11 Bitesnap
  62. 8.11.1 Bitesnap Company Information
  63. 8.11.2 Bitesnap Business Overview
  64. 8.11.3 Bitesnap Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bitesnap Chronic Disease Nutritional Intervention Solution Product Portfolio
  66. 8.11.5 Bitesnap Recent Developments
  67. 8.12 Nutrix
  68. 8.12.1 Nutrix Company Information
  69. 8.12.2 Nutrix Business Overview
  70. 8.12.3 Nutrix Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nutrix Chronic Disease Nutritional Intervention Solution Product Portfolio
  72. 8.12.5 Nutrix Recent Developments
  73. 8.13 Spoon Guru
  74. 8.13.1 Spoon Guru Company Information
  75. 8.13.2 Spoon Guru Business Overview
  76. 8.13.3 Spoon Guru Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Spoon Guru Chronic Disease Nutritional Intervention Solution Product Portfolio
  78. 8.13.5 Spoon Guru Recent Developments
  79. 8.14 Abbott
  80. 8.14.1 Abbott Company Information
  81. 8.14.2 Abbott Business Overview
  82. 8.14.3 Abbott Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Abbott Chronic Disease Nutritional Intervention Solution Product Portfolio
  84. 8.14.5 Abbott Recent Developments
  85. 8.15 Gushengtang Holdings
  86. 8.15.1 Gushengtang Holdings Company Information
  87. 8.15.2 Gushengtang Holdings Business Overview
  88. 8.15.3 Gushengtang Holdings Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Gushengtang Holdings Chronic Disease Nutritional Intervention Solution Product Portfolio
  90. 8.15.5 Gushengtang Holdings Recent Developments
  91. 8.16 Dong-E-E-Jiao
  92. 8.16.1 Dong-E-E-Jiao Company Information
  93. 8.16.2 Dong-E-E-Jiao Business Overview
  94. 8.16.3 Dong-E-E-Jiao Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Dong-E-E-Jiao Chronic Disease Nutritional Intervention Solution Product Portfolio
  96. 8.16.5 Dong-E-E-Jiao Recent Developments
  97. 8.17 Miaoyijia Information Technology
  98. 8.17.1 Miaoyijia Information Technology Company Information
  99. 8.17.2 Miaoyijia Information Technology Business Overview
  100. 8.17.3 Miaoyijia Information Technology Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Miaoyijia Information Technology Chronic Disease Nutritional Intervention Solution Product Portfolio
  102. 8.17.5 Miaoyijia Information Technology Recent Developments
  103. 8.18 Ping An Healthcare And Technology Company
  104. 8.18.1 Ping An Healthcare And Technology Company Company Information
  105. 8.18.2 Ping An Healthcare And Technology Company Business Overview
  106. 8.18.3 Ping An Healthcare And Technology Company Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Ping An Healthcare And Technology Company Chronic Disease Nutritional Intervention Solution Product Portfolio
  108. 8.18.5 Ping An Healthcare And Technology Company Recent Developments
  109. 8.19 WeDoctor
  110. 8.19.1 WeDoctor Company Information
  111. 8.19.2 WeDoctor Business Overview
  112. 8.19.3 WeDoctor Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  113. 8.19.4 WeDoctor Chronic Disease Nutritional Intervention Solution Product Portfolio
  114. 8.19.5 WeDoctor Recent Developments
  115. 8.20 Shanzhen
  116. 8.20.1 Shanzhen Company Information
  117. 8.20.2 Shanzhen Business Overview
  118. 8.20.3 Shanzhen Chronic Disease Nutritional Intervention Solution Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Shanzhen Chronic Disease Nutritional Intervention Solution Product Portfolio
  120. 8.20.5 Shanzhen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst